Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-21-018218

EVP of Research sold 5,000 shares at $18.30 ($91,500)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Huizinga Robert Bindert EVP of Research 2021-09-07 Sale −5,000 $18.30 $91,500 138,592 D
Open-market sales · 5,000 sh · avg $18.30 · $91,500
Loading xslF345X03/wf-form4_163113139756555.xml…